Health Canada has approved an updated Novavax COVID-19 vaccine to protect against the variants of the virus currently ...

RNA interference (RNAi) technology has gradually become a cutting-edge technology for treating diseases such as genetic ...

Pfizer Inc (NYSE: PFE) presented positive trial data for experimental drug designed for patients suffering from cancer ...

Epidemiologists and a federal health agency have criticized new COVID-19 guidance from Florida Surgeon General Joseph Ladapo ...

Pending authorization of the Omicron KP.2-adapted vaccine by the EC, both the Omicron KP.2-adapted vaccine and the Omicron JN.1-adapted vaccine will be available across the EU, though availability ...

Canaccord Genuity analyst Whitney Ijem maintained a Buy rating on Arcturus Therapeutics (ARCT – Research Report) yesterday and set a ...

Moderna 's (NASDAQ: MRNA) stock fell by 13% on Sept. 12 upon the announcement of extensive cost cuts that would affect a handful of its pipeline programs and terminate a few others. Now, management is ...

Moderna should not be left off the list of interesting investment opportunities, as the company has one of the best pipelines ...

I am deeply troubled by the growing distrust of science in our society, just at the time when its insights are most needed.

Breakthroughs in the field are rare, but we have an impressive catalogue of possible solutions to real-word problems.

Shares of Moderna Inc. MRNA slipped 2.63% to $68.02 Thursday, on what proved to be an all-around favorable trading session ...